Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hangzhou Hanx Biopharmaceuticals, Ltd.
University of Pittsburgh
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Genentech, Inc.
Boehringer Ingelheim
The Netherlands Cancer Institute
Canadian Cancer Trials Group
Diakonos Oncology Corporation
Immatics US, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Toray Industries, Inc
National Cancer Institute (NCI)
Providence Health & Services
University of Pittsburgh
7 Hills Pharma, LLC
Istituto Oncologico Veneto IRCCS
Merck Sharp & Dohme LLC
KaliVir Immunotherapeutics
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
Iovance Biotherapeutics, Inc.
NRG Oncology
M.D. Anderson Cancer Center
Replimune Inc.
National Institutes of Health Clinical Center (CC)
Novartis
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
Aulos Bioscience, Inc.
Ipsen
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Pfizer
Pfizer
Obsidian Therapeutics, Inc.
Georgiamune Inc
Canadian Cancer Trials Group
Universität Duisburg-Essen
Institute of Health Information and Statistics of the Czech Republic
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center